Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 3
2024 1
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico.
Arrobas Velilla T, Fernández Prendes C, Amigó Grau N, Calmarza P, Camós Anguila S, Candas Estébanez B, Castro Castro MJ, Ceacero D, González Martínez I, Martín Palencia M, Puzo Foncillas J, Romero Román C; en nombre de la Comisión de Lipoproteínas y Enfermedades Cardiovasculares de la SEQCML. Arrobas Velilla T, et al. Among authors: gonzalez martinez i. Adv Lab Med. 2025 Mar 3;6(1):17-27. doi: 10.1515/almed-2024-0090. eCollection 2025 Mar. Adv Lab Med. 2025. PMID: 40160393 Free PMC article. Spanish.
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
González-Martínez I, Cerro-Herreros E, Moreno N, García-Rey A, Espinosa-Espinosa J, Carrascosa-Sàez M, Piqueras-Losilla D, Arzumanov A, Seoane-Miraz D, Jad Y, Raz R, Wood MJ, Varela MA, Llamusí B, Artero R. González-Martínez I, et al. Mol Ther Nucleic Acids. 2023 Sep 5;34:102024. doi: 10.1016/j.omtn.2023.09.001. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37744174 Free PMC article.
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.
Cerro-Herreros E, Núñez-Manchón J, Naldaiz-Gastesi N, Carrascosa-Sàez M, García-Rey A, Losilla DP, González-Martínez I, Espinosa-Espinosa J, Moreno K, Poyatos-García J, Vilchez JJ, de Munain AL, Suelves M, Nogales-Gadea G, Llamusí B, Artero R. Cerro-Herreros E, et al. Among authors: gonzalez martinez i. Sci Adv. 2024 Oct 11;10(41):eadn6525. doi: 10.1126/sciadv.adn6525. Epub 2024 Oct 9. Sci Adv. 2024. PMID: 39383229 Free PMC article.
Use of HSALR female mice as a model for the study of myotonic dystrophy type I.
Carrascosa-Sàez M, Colom-Rodrigo A, González-Martínez I, Pérez-Gómez R, García-Rey A, Piqueras-Losilla D, Ballestar A, Llamusí B, Cerro-Herreros E, Artero R. Carrascosa-Sàez M, et al. Among authors: gonzalez martinez i. Lab Anim (NY). 2025 Apr;54(4):92-102. doi: 10.1038/s41684-025-01506-7. Epub 2025 Feb 27. Lab Anim (NY). 2025. PMID: 40016516 Free PMC article.
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
González-Martínez I, Cerro-Herreros E, Carrascosa-Sàez M, García-Rey A, Piqueras-Losilla D, Colom-Rodrigo A, Moreno N, Chakraborty M, Huguet-Lachon A, González-Barriga A, Naldaiz-Gastesi N, Dehesa M, Díaz-Maqueda A, Barquero N, Varela MA, López de Munain A, Eritja R, Gourdon G, López-Castel A, Pérez-Alonso M, Llamusi B, Artero R. González-Martínez I, et al. Am J Hum Genet. 2026 Mar 5;113(3):529-547. doi: 10.1016/j.ajhg.2026.01.016. Epub 2026 Feb 20. Am J Hum Genet. 2026. PMID: 41722569 Free PMC article.
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy.
Cerro-Herreros E, González-Martínez I, Moreno-Cervera N, Overby S, Pérez-Alonso M, Llamusí B, Artero R. Cerro-Herreros E, et al. Among authors: gonzalez martinez i. Mol Ther Nucleic Acids. 2020 Sep 4;21:837-849. doi: 10.1016/j.omtn.2020.07.021. Epub 2020 Jul 21. Mol Ther Nucleic Acids. 2020. PMID: 32805487 Free PMC article.
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory.
Velilla TA, Prendes CF, Grau NA, Calmarza P, Anguila SC, Estébanez BC, Castro MJC, Ceacero D, Martínez IG, Palencia MM, Foncillas JP, Román CR; SEQCML Working Group on Lipoproteins and Cardiovascular Diseases. Velilla TA, et al. Among authors: martinez ig. Adv Lab Med. 2025 Mar 3;6(1):7-16. doi: 10.1515/almed-2025-0034. eCollection 2025 Mar. Adv Lab Med. 2025. PMID: 40160391 Free PMC article.
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice.
Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-Martínez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T, Llamusí B, Artero R. Overby SJ, et al. Among authors: gonzalez martinez i. Pharmaceutics. 2023 Mar 31;15(4):1118. doi: 10.3390/pharmaceutics15041118. Pharmaceutics. 2023. PMID: 37111604 Free PMC article.
Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome.
Bermejo-Guerrero L, de Fuenmayor-Fernández de la Hoz CP, Guerrero-Molina MP, Martín-Jiménez P, Blázquez A, Serrano-Lorenzo P, Lora D, Morales-Conejo M, González-Martínez I, López-Jiménez EA, Martín MA, Domínguez-González C. Bermejo-Guerrero L, et al. Among authors: gonzalez martinez i. J Clin Med. 2023 Mar 22;12(6):2435. doi: 10.3390/jcm12062435. J Clin Med. 2023. PMID: 36983435 Free PMC article.
13 results